RhumbLine Advisers’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.17M Sell
220,949
-5,682
-3% -$103K ﹤0.01% 1389
2025
Q4
$3.22M Buy
226,631
+10,284
+5% +$195K ﹤0.01% 1626
2025
Q3
$5.36M Sell
216,347
-33,127
-13% -$739K ﹤0.01% 1401
2025
Q2
$5.66M Sell
249,474
-1,400
-0.6% -$33.2K ﹤0.01% 1341
2025
Q1
$7.61M Sell
250,874
-2,163
-0.9% -$82.4K 0.01% 1142
2024
Q4
$10M Buy
253,037
+11,033
+5% +$498K 0.01% 1056
2024
Q3
$15.3M Sell
242,004
-3,019
-1% -$218K 0.01% 866
2024
Q2
$16.5M Sell
245,023
-874
-0.4% -$61K 0.02% 780
2024
Q1
$19.5M Sell
245,897
-10,599
-4% -$867K 0.02% 722
2023
Q4
$19.9M Sell
256,496
-11,986
-4% -$887K 0.02% 685
2023
Q3
$18.9M Sell
268,482
-7,920
-3% -$592K 0.02% 658
2023
Q2
$22M Buy
276,402
+11,111
+4% +$803K 0.02% 603
2023
Q1
$19.2M Sell
265,291
-2,653
-1% -$207K 0.02% 627
2022
Q4
$22.1M Buy
267,944
+3,776
+1% +$311K 0.03% 543
2022
Q3
$20.7M Buy
264,168
+7,308
+3% +$584K 0.03% 507
2022
Q2
$17.4M Buy
256,860
+25,555
+11% +$1.78M 0.03% 609
2022
Q1
$15.2M Sell
231,305
-6,549
-3% -$380K 0.02% 722
2021
Q4
$14.4M Buy
237,854
+8,302
+4% +$495K 0.02% 772
2021
Q3
$14.6M Sell
229,552
-7,821
-3% -$494K 0.02% 753
2021
Q2
$14.9M Sell
237,373
-4,669
-2% -$293K 0.02% 773
2021
Q1
$13.8M Sell
242,042
-1,644
-0.7% -$89K 0.02% 794
2020
Q4
$12.2M Buy
243,686
+12,392
+5% +$494K 0.02% 800
2020
Q3
$6.82M Sell
231,294
-7,166
-3% -$208K 0.01% 973
2020
Q2
$5.99M Buy
238,460
+5,168
+2% +$129K 0.01% 1090
2020
Q1
$4.28M Buy
233,292
+20,953
+10% +$600K 0.01% 1122
2019
Q4
$7.05M Buy
212,339
+76
+0% +$2.38K 0.01% 1050
2019
Q3
$6.6M Sell
212,263
-530
-0.2% -$16.1K 0.01% 1034
2019
Q2
$7.44M Sell
212,793
-993
-0.5% -$32.1K 0.01% 955
2019
Q1
$6.27M Sell
213,786
-8,701
-4% -$246K 0.01% 1046
2018
Q4
$5.72M Buy
222,487
+69,914
+46% +$2.42M 0.01% 1017
2018
Q3
$5.37M Buy
152,573
+3,698
+2% +$147K 0.01% 1063
2018
Q2
$6.09M Buy
148,875
+6,468
+5% +$261K 0.01% 972
2018
Q1
$5.58M Sell
142,407
-4,480
-3% -$164K 0.01% 968
2017
Q4
$4.79M Sell
146,887
-5,565
-4% -$193K 0.01% 1092
2017
Q3
$7.28M Buy
152,452
+11,352
+8% +$553K 0.02% 829
2017
Q2
$6.97M Buy
141,100
+59,077
+72% +$2.62M 0.02% 817
2017
Q1
$3.58M Buy
82,023
+4,435
+6% +$180K 0.01% 1213
2016
Q4
$2.57M Buy
77,588
+6,609
+9% +$256K 0.01% 1302
2016
Q3
$3.52M Buy
70,979
+3,240
+5% +$169K 0.01% 1076
2016
Q2
$3.75M Buy
67,739
+6,796
+11% +$397K 0.01% 975
2016
Q1
$3.36M Buy
60,943
+7,745
+15% +$442K 0.01% 1060
2015
Q4
$3.32M Buy
53,198
+3,045
+6% +$198K 0.01% 1052
2015
Q3
$3.32M Buy
50,153
+4,005
+9% +$308K 0.01% 1037
2015
Q2
$3.62M Buy
46,148
+3,088
+7% +$222K 0.01% 1036
2015
Q1
$3.08M Buy
43,060
+6,505
+18% +$417K 0.01% 1112
2014
Q4
$2.24M Buy
36,555
+575
+2% +$33.5K 0.01% 1277
2014
Q3
$1.75M Buy
35,980
+2,115
+6% +$103K 0.01% 1415
2014
Q2
$1.54M Buy
33,865
+583
+2% +$25.6K ﹤0.01% 1550
2014
Q1
$1.5M Sell
33,282
-1,340
-4% -$66.1K ﹤0.01% 1538
2013
Q4
$1.64M Sell
34,622
-60
-0.2% -$2.61K ﹤0.01% 1491
2013
Q3
$1.37M Sell
34,682
-23
-0.1% -$854 ﹤0.01% 1569
2013
Q2
$1.15M Buy
+34,705
New +$1.13M ﹤0.01% 1661

Other funds holding ACHC

RhumbLine Advisers's ACHC Position: Q1 2026 in Review

RhumbLine Advisers reduced its Acadia Healthcare (ACHC) stake by 2.5% in Q1 2026, selling an estimated $103K and leaving 220,949 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

RhumbLine Advisers first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.1M in Q4 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • RhumbLine Advisers held 220,949 shares of Acadia Healthcare worth $5.17M as of Q1 2026.
  • RhumbLine Advisers sold 5,682 Acadia Healthcare shares in Q1 2026, an estimated $103K.
  • Acadia Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1389 holding.
  • RhumbLine Advisers first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • RhumbLine Advisers's Acadia Healthcare position peaked at $22.1M in Q4 2022.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.